Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent-Reference-Cited by-同舟云学术

Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent

Published:1996-11 Issue:6 Volume:75 Page:300-326
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:Medicine

Author:

Charache Samuel,Barton Franca B.,Moore Richard D.,Terrin Michael L.,Steinberg Martin H.,Dover George J.,Ballas Samir K.,McMahon Robert P.,Castro Oswaldo,Orringer Eugene P.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference108 articles.

1. Cerebral infarction in sickle cell anemia: Mechanism based on CT and MRI

2. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells

3. Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis

Cited by 291 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fostering a healthier generation of children with sickle cell disease through advancements in care;Pediatric Research;2024-09-13

2. The impact of sickle cell disease and its treatment on ovarian reserve in reproductive‐aged Black women;British Journal of Haematology;2024-06-06

3. Impact of hospitalized vaso-occlusive crises in the previous calendar year on mortality and complications in adults with sickle cell disease: a French population-based study;The Lancet Regional Health - Europe;2024-05

4. Hemolysis dictates monocyte differentiation via two distinct pathways in sickle cell disease vaso-occlusion;Journal of Clinical Investigation;2023-09-15

5. “Buprenorphine, It Works so Differently”: Adults with Sickle Cell Disease Describe Transitioning to Buprenorphine for Treatment of Chronic Pain;The Journal of Pain;2023-09